Estimation after subpopulation selection in adaptive seamless trials

Adaptive Designs for Confirmatory Clinical Trials with Subgroup Selection

(2014) Nigel Stallard et al.   Journal of Biopharmaceutical Statistics

A comparison of methods for constructing confidence intervals after phase II/III clinical trials

(2013) Peter K. Kimani et al.   BIOMETRICAL JOURNAL

Simultaneous confidence intervals that are compatible with closed testing in adaptive designs

(2013) D. Magirr et al.   BIOMETRIKA

Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility

(2013) Peter K. Kimani et al.   STATISTICS IN MEDICINE

A conditional error function approach for subgroup selection in adaptive clinical trials

(2012) T. Friede et al.   STATISTICS IN MEDICINE

Shrinkage estimation in two-stage adaptive designs with midtrial treatment selection

(2012) Máximo Carreras et al.   STATISTICS IN MEDICINE

Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods

(2012) Peter K. Kimani et al.   STATISTICS IN MEDICINE

Efficacy of vagus nerve stimulation for refractory epilepsy among patient subgroups: A re-analysis using the Engel classification

(2011) Marcus Wheeler et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Interval estimation in two-stage, drop-the-losers clinical trials with flexible treatment selection

(2011) Dan Neal et al.   STATISTICS IN MEDICINE

Cementless total hip arthroplasty for primary osteoarthritis in patients aged 55 years and older

(2010) Keijo T Mäkelä et al.   Acta Orthopaedica

Interval estimation for drop-the-losers designs

(2010) S. S. Wu et al.   BIOMETRIKA

Adjusted significance levels for subgroup analyses in clinical trials

(2010) Bart Spiessens et al.   Contemporary Clinical Trials

An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints†

(2010) Martin Jenkins et al.   PHARMACEUTICAL STATISTICS

Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology

(2009) Werner Brannath et al.   STATISTICS IN MEDICINE

Dose selection in seamless phase II/III clinical trials based on efficacy and safety

(2009) Peter K. Kimani et al.   STATISTICS IN MEDICINE

Unbiased Estimation of Selected Treatment Means in Two-Stage Trials

(2008) Jack Bowden et al.   BIOMETRICAL JOURNAL

Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

(2008) Rafael G. Amado et al.   JOURNAL OF CLINICAL ONCOLOGY

Estimation following selection of the largest of two normal means

(2007) Nigel Stallard et al.   JOURNAL OF STATISTICAL PLANNING AND INFERENCE